Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Burn Care Res ; 42(5): 975-980, 2021 09 30.
Article in English | MEDLINE | ID: mdl-33515461

ABSTRACT

In the surgical suture, the implanted thread can be a source of microbial contamination. Implanted materials are frequently described as being substrates prone for biofilm development provoking surgical site infections. Treatment of postsurgical wounds with different topical antimicrobial agents is a current practice applied to every patient. However, to date, there is little evidence on the efficacy of different antiseptic treatments on suture materials in preventing environmental or skin bacterial adhesion and further infection. Here, the authors compared the ability of an aerosol formulation of silver sulfadiazine, vitamin A, and lidocaine (AF-SSD) and of two of the most frequently used topical treatments, povidone-iodine and ethanol, in eradicating or controlling the microbial contamination of suture threads in patients who have undergone clean surgeries. Postsurgical suture threads treated with AF-SSD showed a significantly reduced proportion of contaminated samples containing viable microbial cells compared with those treated with povidone-iodine or ethanol. Furthermore, those samples that were positive for bacterial growth showed a lesser number of viable cells in AF-SSD-treated sutures than those treated with povidone-iodine or ethanol. Confocal laser scanning microscopy showed that AF-SSD-treated postsurgical sutures presented significantly less attached microbial cells than povidone-iodine and ethanol, with scarce observable microbial cells on the surface of the suture. Taken together, the results suggest that treatment with AF-SSD is more effective than the other two antiseptics, and there is a potential for improvement in reducing the microbial burden of implanted materials such as the suture thread.


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Burns/therapy , Ethanol/therapeutic use , Povidone-Iodine/therapeutic use , Silver Sulfadiazine/therapeutic use , Surgical Wound Infection/prevention & control , Administration, Topical , Aerosols , Burns/drug therapy , Follow-Up Studies , Humans , Sutures , Wound Healing
2.
Burns ; 46(1): 128-135, 2020 02.
Article in English | MEDLINE | ID: mdl-31420266

ABSTRACT

The risk of infection of skin and soft tissue chronic wounds by gram-negative and gram-positive pathogens growing in biofilms is a major health-care concern. In this study we test a formulation of silver sulfadiazine, vitamin A and lidocaine (AF-SSD) for aerosol administration against biofilms of Pseudomonas aeruginosa and biofilms of methicillin-resistant (MRSA) and methicillin-sensitive (MSSA) strains of Staphylococcus aureus. The aerosol allows the administration of AF-SSD without the direct contact with the wound and avoids contamination of the product after reiterative usage. We evaluated in vitro the anti-biofilm activity of AF-SSD by carrying out different technical approaches such as resazurin assays to measure metabolic activity/viability, crystal violet staining assays to determine biofilm biomass, counting of CFUs and live/dead staining for confocal microscopy analysis. AF-SSD clearly affected biofilm viability, biomass and structure, in the three bacterial strains tested. AF-SSD displayed a strong anti-biofilm effect, showing total bactericidal activity on biofilms of P. aeruginosa at a 400-fold dilution of the product, and after a 100-fold and 10-fold dilution for MRSA and MSSA, respectively. Considering the benefits of aerosol administration, our results support this kind of formulation as a potential improvement over conventional treatments with silver sulfadiazine.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Biofilms/drug effects , Methicillin-Resistant Staphylococcus aureus/drug effects , Microbial Viability/drug effects , Pseudomonas aeruginosa/drug effects , Silver Sulfadiazine/pharmacology , Aerosols , Anesthetics, Local/administration & dosage , Anesthetics, Local/pharmacology , Anti-Infective Agents, Local/administration & dosage , Drug Combinations , In Vitro Techniques , Lidocaine/administration & dosage , Lidocaine/pharmacology , Methicillin-Resistant Staphylococcus aureus/growth & development , Methicillin-Resistant Staphylococcus aureus/metabolism , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/metabolism , Silver Sulfadiazine/administration & dosage , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development , Staphylococcus aureus/metabolism , Vitamin A/administration & dosage , Vitamin A/pharmacology , Vitamins/administration & dosage , Vitamins/pharmacology
3.
Neurochem Res ; 27(11): 1453-8, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12512949

ABSTRACT

In this paper we describe the cloning of rat olfactory bulb tubulin tyrosine ligase (TTL) cDNA, and investigate the physiological role of TTL in cultured CHO-K1 cells. Comparison of the deduced amino acid sequence of rat TTL cDNA with those of bovine and pig showed approximately 90% of identity. Transient transfection of CHO-K1 cells with a dominant negative mutant of TTL that contains the binding site to the substrate (tubulin) but not the catalytic domain, significantly decreased the endogenous TTL activity as determined in vitro. Similar results were obtained using a construction encoding for the antisense sequence of TTL. The reduction in TTL activity is not accompanied by a decrease in the tyrosination levels of microtubules, as judged by immunofluorescence analysis. Strikingly, the number of cells in the plates transfected with the mutant TTL or the antisense TTL cDNA was, after 72 h of culture, two and three times higher, respectively, than the number of cells in the control plates. These results support the hypothesis that TTL may play a role in the regulation of the cell cycle in living cells.


Subject(s)
Cell Division/genetics , Olfactory Bulb/enzymology , Peptide Synthases/genetics , Amino Acid Sequence , Animals , Base Sequence , CHO Cells , Cell Division/drug effects , Cloning, Molecular , Cricetinae , DNA, Antisense/pharmacology , DNA, Complementary , Microtubules/metabolism , Molecular Sequence Data , Mutation , Peptide Synthases/chemistry , Peptide Synthases/metabolism , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...